LungVITamin D and OmegA-3 Trial (lungVITAL)
Not Applicable
Active, not recruiting
- Conditions
- PneumoniaPulmonary FunctionCOPDAsthma
- Interventions
- Dietary Supplement: Vitamin D3Dietary Supplement: fish oilDietary Supplement: Fish oil placeboDietary Supplement: Vitamin D3 placebo
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 25871
- Registration Number
- NCT01728571
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study A
Not Applicable
Completed
- Conditions
- Obstructive Sleep ApneaPathophysiology
- Interventions
- Other: Pharyngeal topical anesthesia
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2019-07-11
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT01728974
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Identification of Undiagnosed Gaucher Disease
Not Applicable
- Conditions
- Gaucher Disease
- Interventions
- Other: Enzyme analysis
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2012-10-30
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01716741
- Locations
- 🇺🇸
Brigham and Women's Hosptial, Boston, Massachusetts, United States
Assessment of Sleep Apnea and Its Causes Before and After Weight Loss Surgery
Not Applicable
Terminated
- Conditions
- Sleep Apnea, Obstructive
- Interventions
- Procedure: Weight-loss (bariatric) surgery
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01712269
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers
Not Applicable
Completed
- Conditions
- Fractures
- Interventions
- Dietary Supplement: Vitamin D3 placeboDietary Supplement: Fish oil placeboDietary Supplement: Vitamin D3
- First Posted Date
- 2012-10-12
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 25871
- Registration Number
- NCT01704859
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Riluzole Augmentation Pilot in Depression (RAPID) Trial
Phase 2
Terminated
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2012-10-10
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT01703039
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Evaluation of Lysine-Specific Demethylase 1
Not Applicable
Withdrawn
- Conditions
- Hypertension
- First Posted Date
- 2012-10-08
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT01702688
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Functional Applications of Hyperpolarized 129Xe MRI
Phase 1
Terminated
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Hyperpolarized 129Xe gas
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 1
- Registration Number
- NCT01697332
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Not Applicable
Active, not recruiting
- Conditions
- Depressive SymptomsMoodDepression
- Interventions
- Dietary Supplement: vitamin D3Dietary Supplement: Fish oil placeboDietary Supplement: Vitamin D placebo
- First Posted Date
- 2012-10-01
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 18353
- Registration Number
- NCT01696435
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 41
- Registration Number
- NCT01691781
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath